Clinical Trials for BioMed Valley Discoveries

Explore 7 clinical trials worldwide

Showing 1-7 of 7 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: BioMed Valley Discoveries

Clinical Trials (7)

NCT06773195
A Study of Ruxolitinib in Combination With Ulixertinib in People With Myelofibrosis
PHASE1/PHASE2Recruiting
37 participants
Started: Jan 7, 2025 · Completed: Jan 31, 2028
1 condition3 sponsors9 locations
NCT06411821
Ulixertinib in People With Histiocytic Neoplasms
PHASE2Recruiting
38 participants
Started: May 7, 2024 · Completed: May 31, 2027
1 condition2 sponsors8 locations
NCT05985954
Open-label Phase 1b Study of Ulixertinib and Cetuximab or Ulixertinib in Combination With Cetuximab and Encorafenib in Patients With Unresectable or Metastatic Colorectal Cancer Who Have Previously Received EGFR or BRAF-directed Therapy
PHASE1Recruiting
27 participants
Started: Jan 18, 2024 · Completed: Mar 28, 2028
1 condition3 sponsors1 location
NCT05804227
Window-of-Opportunity Trial of Ulixertinib for MAPK-Activated Gliomas
EARLY_PHASE1Recruiting
20 participants
Started: Apr 20, 2023 · Completed: Sep 22, 2027
1 condition2 sponsors1 location
NCT03435952
Pembrolizumab With Intratumoral Injection of Clostridium Novyi-NT
PHASE1Active, not recruiting
18 participants
Started: Jul 10, 2018 · Completed: Oct 1, 2026
12 conditions3 sponsors1 location
NCT03417739
A Phase II Study of BVD-523 in Metastatic Uveal Melanoma
PHASE2Active, not recruiting
13 participants
Started: Mar 26, 2018 · Completed: Aug 31, 2025
1 condition2 sponsors2 locations
NCT03454035
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
PHASE1Recruiting
45 participants
Started: Jan 30, 2018 · Completed: Nov 24, 2026
3 conditions3 sponsors1 location